Showing posts with label Catalytic therapy of cancer. Show all posts
Showing posts with label Catalytic therapy of cancer. Show all posts

Sunday, February 10, 2013

Catalytic therapy of cancer with porphyrins and ascorbate.

Department of Chemistry and Biochemistry, University of California, Santa Cruz, CA 95064, USA. rozanovan@hotmail.com Abstract Catalytic therapy (CT) is a cancer treatment modality based on the generation of reactive oxygen species (ROS) using a combination of substrate molecules and a catalyst. In addition, the number of cells accumulating in the sub G0/G1 stage of the cell cycle increased from 3- to 10-fold, potentially reflecting that the treatment was highly effective in inducing DNA damage in the tumor cells, suggesting that porphyrins may be beneficial as a CT catalyst in the treatment of cancer.

Catalytic therapy of cancer with ascorbate and extracts of medicinal herbs.

Department of Chemistry and Biochemistry, University of California, Santa Cruz, CA 95064 and Department of Cancer Biology and Pharmacology, University of Illinois College of Medicine, Peoria, IL 61605, USA. Abstract Catalytic therapy (CT) is a cancer treatment modality based on the generation of reactive oxygen species (ROS) using a combination of substrate molecules and a catalyst. The most frequently used substrate/catalyst pair is ascorbate/Co phthalocyanine (PcCo). indicating that the treatment protocol was highly effective in suppressing DNA synthesis and potentially reflecting DNA damage in the tumor cells. Our results suggest that herbal extracts can function as CT catalysts in the treatment of cancer.

Labels